Clarification sought from Sun Pharmaceutical Industries

16 Feb 2017 Evaluate

The Exchange has sought clarification from Sun Pharmaceutical Industries on February 16, 2017, with reference to news appeared in CNBC TV 18 dated February 16, 2017 ‘UK Regulator approves Sun Pharma Generic drug of Tobramycin.’

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1589.30 -20.85 (-1.29%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×